These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16570098)

  • 1. The endocannabinoid system and its role in energy homeostasis and abdominal obesity management. Proceedings of a meeting, Quebec City, Canada, 20 November 2004.
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S1-52. PubMed ID: 16570098
    [No Abstract]   [Full Text] [Related]  

  • 2. [Endocannabinoid system and energy metabolism: physiology and pathophysiology].
    Pagotto U; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):74S-82S. PubMed ID: 18773754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia.
    Matias I; Gonthier MP; Orlando P; Martiadis V; De Petrocellis L; Cervino C; Petrosino S; Hoareau L; Festy F; Pasquali R; Roche R; Maj M; Pagotto U; Monteleone P; Di Marzo V
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3171-80. PubMed ID: 16684820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid system and cardiometabolic risk.
    Saavedra LE
    Clin Pharmacol Ther; 2007 Nov; 82(5):591-4. PubMed ID: 17898706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The endocannabinoid system as a novel approach for managing obesity.
    Lillo JL
    J Am Osteopath Assoc; 2007 Apr; 107(4 Suppl 2):S12-20. PubMed ID: 17784530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The endocannabinoid system and cardiometabolic risk.
    Szmitko PE; Verma S
    Atherosclerosis; 2008 Aug; 199(2):248-56. PubMed ID: 18440538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The endocannabinoid system and the control of glucose homeostasis.
    Nogueiras R; Rohner-Jeanrenaud F; Woods SC; Tschöp MH
    J Neuroendocrinol; 2008 May; 20 Suppl 1():147-51. PubMed ID: 18426514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of the endocannabinoid system for the reduction of cardiometabolic risk factors.
    Samaha FF; Chou CM
    Obesity (Silver Spring); 2009 Feb; 17(2):220-5. PubMed ID: 19039319
    [No Abstract]   [Full Text] [Related]  

  • 9. [The endocannabinoid system: a new paradigm in the metabolic syndrome treatment].
    de Godoy-Matos AF; Guedes EP; de Souza LL; Valério CM
    Arq Bras Endocrinol Metabol; 2006 Apr; 50(2):390-9. PubMed ID: 16767305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minireview: Endocannabinoids and their receptors as targets for obesity therapy.
    de Kloet AD; Woods SC
    Endocrinology; 2009 Jun; 150(6):2531-6. PubMed ID: 19372200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid control of food intake and energy balance.
    Di Marzo V; Matias I
    Nat Neurosci; 2005 May; 8(5):585-9. PubMed ID: 15856067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
    Pagotto U; Marsicano G; Cota D; Lutz B; Pasquali R
    Endocr Rev; 2006 Feb; 27(1):73-100. PubMed ID: 16306385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The endocannabinoid system].
    Sudano I; Périat D; Noll G
    Praxis (Bern 1994); 2008 Apr; 97(7):375-80. PubMed ID: 18548817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The brain endocannabinoid system in the regulation of energy balance.
    Richard D; Guesdon B; Timofeeva E
    Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):17-32. PubMed ID: 19285258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of PUFAs, the precursors of endocannabinoids, in human obesity and type 2 diabetes.
    Dain A; Repossi G; Das UN; Eynard AR
    Front Biosci (Elite Ed); 2010 Jun; 2(4):1432-47. PubMed ID: 20515815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Endocannabinoid system: new perspectives in the global management of cardiometabolic risk factors].
    Maldonado R
    Med Clin (Barc); 2008 May; 130(16):615-22. PubMed ID: 18482529
    [No Abstract]   [Full Text] [Related]  

  • 17. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of the endocannabinoid system in the regulation of endocrine function and in the control of energy balance in humans].
    Komorowski J; Stepień H
    Postepy Hig Med Dosw (Online); 2007; 61():99-105. PubMed ID: 17369778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The endocannabinoid system and its relevance for nutrition.
    Maccarrone M; Gasperi V; Catani MV; Diep TA; Dainese E; Hansen HS; Avigliano L
    Annu Rev Nutr; 2010 Aug; 30():423-40. PubMed ID: 20645854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity.
    Heyman E; Gamelin FX; Aucouturier J; Di Marzo V
    Obes Rev; 2012 Dec; 13(12):1110-24. PubMed ID: 22943701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.